Hui Zhang | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Hui Zhang | Clinical Neuroscience | Best Researcher Award

Prof. Hui Zhang | Northwestern University | United States

Hui Zhang is a Professor in the Division of Biostatistics, Department of Preventive Medicine at Northwestern University Feinberg School of Medicine, where he also holds appointments at the Robert H. Lurie Comprehensive Cancer Center, the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease, and the Center for Epidemiology and Population Health. he serves as Director of the Northwestern Brain Tumor SPORE Biostatistics and Bioinformatics Core and leads the Biostatistics and Data Management Core at the Mesulam Center. With a Ph.D. in Statistics from the University of Rochester, her academic foundation spans pharmacology, neurophysiology, and biology, reflecting her interdisciplinary expertise in biostatistics and biomedical research. His previous experience includes research roles at St. Jude Children’s Research Hospital, where she contributed significantly to clinical and statistical protocol development. Professor Zhang’s work focuses on statistical methodologies for cancer and neurological disease research, data integration, and bioinformatics applications. he is an active member of several professional societies, including the American Statistical Association and the International Chinese Statistical Association. A highly cited researcher, she has accumulated over 11,422 citations, an h-index of 43, and an i10-index of 100, demonstrating her substantial impact and leadership in the fields of biostatistics and medical data science.

Profile: Google Scholar

Featured Publications

Moss, A. J., Hall, W. J., Cannom, D. S., Klein, H., Brown, M. W., Daubert, J. P., et al. (2009). Cardiac-resynchronization therapy for the prevention of heart-failure events. New England Journal of Medicine, 361(14), 1329–1338.

Gunzler, D., Chen, T., Wu, P., & Zhang, H. (2013). Introduction to mediation analysis with structural equation modeling. Shanghai Archives of Psychiatry, 25(6), 390–394.

Wan, T., Jun, H. U., Pan, W. U., & Hua, H. E. (2015). Kappa coefficient: A popular measure of rater agreement. Shanghai Archives of Psychiatry, 27(1), 62–67.

Pu, J., Wang, S., Yin, Y., Zhang, G., Carter, R. A., Wang, J., Xu, G., Sun, H., Wang, M., et al. (2015). Evolution of the H9N2 influenza genotype that facilitated the genesis of the novel H7N9 virus. Proceedings of the National Academy of Sciences, 112(2), 548–553.

Guy, C. S., Vignali, K. M., Temirov, J., Bettini, M. L., Overacre, A. E., Smeltzer, M., et al. (2013). Distinct TCR signaling pathways drive proliferation and cytokine production in T cells. Nature Immunology, 14(3), 262–270.

Shen, S., Chen, X., Cai, J., Yu, J., Gao, J., Hu, S., Zhai, X., Liang, C., Ju, X., Jiang, H., et al. (2020). Effect of dasatinib vs imatinib in the treatment of pediatric Philadelphia chromosome–positive acute lymphoblastic leukemia: A randomized clinical trial. JAMA Oncology, 6(3), 358–366.

Sonabend, A. M., Gould, A., Amidei, C., Ward, R., Schmidt, K. A., Zhang, D. Y., et al. (2023). Repeated blood–brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: A phase 1 trial. The Lancet Oncology, 24(5), 509–522.

Maansi Solanky | Molecular and Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Ms. Maansi Solanky | Molecular and Cellular Neuroscience | Best Researcher Award

Ms. Maansi Solanky | LSU Health New Orleans | United States

Maansi Solanky is a dedicated medical scholar pursuing her Doctor of Medicine at LSU Health New Orleans, with a strong interdisciplinary background in health and human sciences from the University of Southern California. Her academic journey integrates medicine, analytics, and public health, reflected in her extensive research and operational experience across multiple institutions. As an Operations Analyst at Evergreen Nephrology, she contributed to improving healthcare delivery through data-driven solutions, process optimization, and interdepartmental collaboration. Her research at the USC Keck School of Medicine explored neural communication mechanisms underlying schizophrenia and analyzed food insecurity in Los Angeles County using advanced data analytics. Additionally, her work with the Louisiana Organ Procurement Agency led to actionable insights enhancing organ donation efficiency through comparative data modeling in R, SQL, and SAS. With teaching experience as a Chemistry Supplemental Instruction Leader for over 700 students, she demonstrates a passion for mentorship and education. Maansi is also deeply engaged in community initiatives promoting public health and equitable healthcare access. She has authored 5 research documents, accumulated 42 citations, and holds an H-index of 3, underscoring her growing influence in medical research and data-driven healthcare innovation.

Profile: Oricd

Featured Publication

Solanky, M., Khosla, M., & Alahari, S. K. (2025). Assessing the tumor suppressive impact and regulatory mechanisms of SPDEF expression in breast cancer. Cancers, 17(21), 3556.

Kushal J | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mr. Kushal J | Clinical Neuroscience | Best Researcher Award

Mr. Kushal J |  Acharya and B M Reddy College of Pharmacy | India

Kushal J’s research focuses on pharmaceutical analysis, drug formulation, and healthcare innovation, reflecting a deep interest in bridging traditional and modern approaches to drug development. His work includes the formulation, development, and evaluation of an anti-acne serum using cow’s urine, a study that explores bioactive natural resources for dermatological applications. He has also contributed to analytical chemistry through his project on analytical method development and validation for identifying selected genotoxic impurities in bulk and pharmaceutical dosage forms by the RP-HPLC DAD method, presented at the JSS Pharmanecia International Research Conference. His academic training emphasizes analytical instrumentation, including HPLC, UV-Vis spectrophotometry, and dissolution testing, supported by a strong understanding of Good Laboratory Practices (GLP) and Good Manufacturing Practices (GMP). He has further strengthened his theoretical foundation through certifications in Food Chemistry and Biomedical Research. Kushal’s growing research portfolio highlights his dedication to advancing pharmaceutical quality control, regulatory compliance, and innovation in formulation science. His goal is to apply analytical and formulation expertise toward developing safer, more effective, and sustainable pharmaceutical products, contributing to the evolving fields of pharmaceutical technology, analytical method development, and health informatics.

Profile: Orcid

Featured Publication

Kushal, J., Loganathan, C. G., Rajesh, R., Dutta, S., Paik, A., Dasgupta, A., Reddy, G. N. N., & Suchindar, A. (2025). Recent advances in quinoline derivatives: Biological and medicinal insights. ChemistrySelect.

Eleonora Bieber | Developmental Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Eleonora Bieber | Developmental Neuroscience | Best Researcher Award

Dr. Eleonora Bieber | IRCCS Fondazione Stella Maris | Italy

Dr. Eleonora Bieber is a highly experienced neurodevelopmental disorder therapist and biomedical scientist based in Livorno, Italy, with over 15 years of expertise in pediatric neurorehabilitation, higher education, and clinical research. Her professional work integrates clinical practice with academic innovation, focusing on motor learning and imitation processes in children with Autism Spectrum Disorder (ASD) and Developmental Coordination Disorders (DCD). At the IRCCS Stella Maris Foundation in Pisa, she has played a key role in conducting clinical evaluations, designing individualized rehabilitation programs, and leading research initiatives that bridge clinical and academic environments. Her involvement in cutting-edge projects, such as INNOVATivE Technologies in Neurorehabilitation and the Artificial Intelligence and Cerebral Palsy (AINCP) project, underscores her commitment to technological innovation in neurorehabilitation. With strong skills in research design, SPSS-based data analysis, and interdisciplinary coordination, Dr. Bieber continues to contribute significantly to advancing evidence-based practices in neurodevelopmental therapy. Her scholarly impact includes 5 publications, 78 citations, and an h-index of 4, reflecting her influence in the field of neurodevelopmental research and her dedication to improving therapeutic outcomes for children through collaborative, technology-enhanced approaches.

Profiles: Scopus | Orcid

Featured Publications

Bieber, E., Smits-Engelsman, B. C. M., Sgandurra, G., Martini, G., Guzzetta, A., Cioni, G., Feys, H., & Klingels, K. (2023). Insights on action observation and imitation abilities in children with Developmental Coordination Disorder and typically developing children. Research in Developmental Disabilities, 136, 104556.

Bieber, E., Smits-Engelsman, B. C. M., Sgandurra, G., Di Gregorio, F., Guzzetta, A., Cioni, G., Feys, H., & Klingels, K. (2021). A new protocol for assessing action observation and imitation abilities in children with Developmental Coordination Disorder: A feasibility and reliability study. Human Movement Science, 78, 102717.

Buchignani, B., Beani, E., Pomeroy, V., Iacono, O., Sicola, E., Perazza, S., Bieber, E., Feys, H., Klingels, K., & Cioni, G. (2019). Action observation training for rehabilitation in brain injuries: A systematic review and meta-analysis. BMC Neurology, 19, 186.

Bieber, E., Smits-Engelsman, B. C. M., Sgandurra, G., Cioni, G., Feys, H., Guzzetta, A., & Klingels, K. (2016). Manual function outcome measures in children with developmental coordination disorder (DCD): Systematic review. Research in Developmental Disabilities, 55, 53–63.

Victoria Carter | Emerging Areas in Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Victoria Carter | Emerging Areas in Neuroscience | Best Researcher Award

Dr. Victoria Carter | VCA West Coast Vet Hospital | United States

Victoria Carter is a highly skilled small-animal internal-medicine clinician and researcher whose diverse training and leadership reflect her commitment to veterinary excellence. After earning a BSc (Hons) in Biological Science from the University of Guelph in Canada, followed by a DVMS (Bachelor of Veterinary Medicine & Surgery) from the Royal (Dick) School of Veterinary Studies in Edinburgh (where she received multiple awards including the CEVA Dermatology Prize and the Outstanding Student Leadership Award), she completed internships, a residency in Small Animal Internal Medicine at the University of Pennsylvania – Matthew J. Ryan Veterinary Hospital, and now serves as one of the lead internal medicine clinicians at the VCA West Coast Specialty & Emergency Animal Hospital in Fountain Valley, CA. Her clinical repertoire includes advanced endoscopic procedures (gastroduodenoscopy, ileocolonoscopy, bronchoscopy, rhinoscopy, cystoscopy/vaginoscopy and tracheoscopy) and she is experienced in high-volume inpatient and outpatient settings, collaborating across hospital services to tailor diagnostics and care plans for complex cases. Her research interests include immune-mediated diseases, such as primary immune-mediated neutropenia in the context of an earlier-diagnosed Evans syndrome in dogs (Carter & Silvestrini, Vet Rec Case Rep) and a retrospective international study on hypercobalaminaemic cats in progress under mentor Paolo Silvestrini MSc, PhD, DECVIM(CA). She has authored [DOCUMENTS-COUNT] publications, amassed [CITATIONS-COUNT] citations, and holds an h-index of [H-INDEX]. A native Canadian, fluent in English and French, she brings strong leadership, communication and interpersonal skills — especially in high-pressure environments — and fosters a positive, collaborative veterinary team culture while building excellent relationships with clients and patients.

Profile: Orcid

Featured Publication

Carter, V., & Silvestrini, P. (2025, September 24). Primary immune‐mediated neutropenia as part of a relapse of previously diagnosed Evans syndrome in a dog. Veterinary Record Case Reports.

Zhou Yu | Behavioral Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Zhou Yu | Behavioral Neuroscience | Best Researcher Award

Dr. Yu Zhou is a postdoctoral researcher at Army Engineering University, specializing in the intersection of neuroscience, computer vision, and target detection. His research primarily focuses on deceptive visual design for both human and machine perception, exploring how visual stimuli can influence detection, recognition, and cognitive processing. Zhou has conducted pioneering studies on camouflage and optical deception, utilizing EEG-based brain functional network analysis to evaluate target visibility and cognitive responses. His work integrates principles from weapon science, biomedical engineering, and computer science to develop comprehensive models of visual perception and deception. Representative publications include investigations into neural responses to camouflage targets with varying exposure signs, the impact of color differences on brain activation patterns, and feasibility assessments of optical camouflage effects. Through these studies, he contributes to a deeper understanding of how visual designs can manipulate human attention and computer vision systems, providing actionable insights for defense technology applications. Zhou’s research emphasizes rigorous quantitative evaluation methods, leveraging neurophysiological data to inform the design of effective deceptive visual patterns. With an h-index of 2 and multiple citations, his work demonstrates a growing influence in fields spanning neuroscience-informed computer vision, perceptual deception, and applied optical camouflage.

Profiles: Scopus | Reasearch Gate

Featured publication

Author(s). (2024). Neural responses to camouflage targets with different exposure signs based on EEG. Neuropsychologia.

Hiroshi Nagase | Neuropharmacology | Best Researcher Award

Published on by Neuroscientists

Prof. Hiroshi Nagase | Neuropharmacology | Best Researcher Award

Prof. Hiroshi Nagase | University of Tsukuba | Japan

Prof. Hiroshi Nagase is a distinguished Japanese scientist recognized for his pioneering contributions to medicinal chemistry and drug discovery. He earned his B.S., M.S., and Ph.D. degrees in Chemistry from Nagoya University, Japan, and later served as a Visiting Scientist at the University of Minnesota’s Department of Medicinal Chemistry. Dr. Nagase began his professional career at Toray Industries Inc., where he advanced from Researcher to Director in the Basic Research Laboratories. He later joined Kitasato University’s School of Pharmacy as a Professor and subsequently served as a Principal Investigator and Professor at the International Institute for Integrative Sleep Medicine (IIIS) under the World Premier International Research Center Initiative at the University of Tsukuba, where he now holds the title of Professor Emeritus. His academic and research influence extended through adjunct professorships at the University of Tokyo, the University of Nagasaki, Toyohashi Polytechnic College, and Nagoya University. Dr. Nagase has authored 39 scientific documents, which have collectively garnered 279 citations from 189 sources, reflecting his substantial impact on the field. With an h-index of 10, his research continues to inspire advancements in medicinal chemistry, neuropharmacology, and therapeutic innovation.

Profiles: Scopus | Research Gate

Featured Publication

Nagase, H. (2025). Development of novel bioactive alkaloids based on specific reactions of the 4,5-epoxymorphinan framework. Synlett.

[Authors not listed]. (2025). Delta opioid receptor agonists activate PI3K–mTORC1 signaling in parvalbumin-positive interneurons in mouse infralimbic prefrontal cortex to exert acute antidepressant-like effects. Molecular Psychiatry.

Liliana Elena Weimer | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Liliana Elena Weimer | Clinical Neuroscience | Best Researcher Award

Dr.  Liliana Elena Weimer, Center For Global Health Istituto Superiore di Sanita’ Rome, Italy.

Dr. Liliana Elena Weimer is a highly accomplished physician and clinical researcher , where she has risen to the prestigious Level II “First Researcher” position. Her professional focus lies in clinical trials for infectious diseases, particularly HIV and Hepatitis C. She has played a critical role in major national and international research efforts, including collaborations with the U.S. Clinical Trials Group and leadership of the large-scale PITER cohort involving 25,000 HCV patients. She is known not only for her scientific contributions but also for her humanitarian efforts during the COVID-19 emergency. Among her recognitions is the 1st Prize at the 2019 International Congress on Hepatitis C in Seville. Throughout her career, she has exemplified scientific integrity, dedication, and service to public health.

Profile

Google Scholar

🎓 Early Academic Pursuits

Born on December 19, 1965, in Buenos Aires to Italian parents, Dr. Liliana Elena Weimer embraced her dual heritage and committed herself to a life in medicine and research. With Italian citizenship and deep academic determination, she laid the groundwork for her career by studying medicine, ultimately finding her professional home in Italy. Her academic path, though not fully detailed, clearly led her toward a focus on clinical medicine and infectious diseases, with her earliest professional roles marking the beginning of a lifelong engagement in public health and biomedical research. Her intellectual dedication and international roots later became an asset in global research collaborations.

🩺 Professional Endeavors

Dr. Weimer’s distinguished career spans over three decades at the Italian National Institute of Health (ISS), beginning in 1985. Starting as a dedicated clinical physician, she ascended to Level III researcher status by 1990 and continued to grow into higher ranks, culminating in her success in the national Art. 15 competition for the Level II “First Researcher” role in 2022, officially backdated to 2021. Throughout her tenure at ISS, she became a central figure within the Global Health Center in Rome. Known for her tireless commitment, she often described her career not simply as a job but as a “mission,” emphasizing both her personal and professional passion for making a difference in human health.

🧪 Contributions and Research Focus

Specializing in clinical trials, Dr. Weimer has coordinated and participated in numerous groundbreaking studies in HIV and Hepatitis C (HCV). Since the early 1990s, she has collaborated closely with renowned figures such as Prof. Giovanni Rossi, Prof. Stefano Vella, and Prof. Gianni Rezza, contributing to some of the most pivotal HIV antiretroviral therapy trials in history. Her research efforts extended to co-leading and organizing both national and international multicenter clinical trials. Notably, she has been at the forefront of the PITER study, a major nationwide cohort that follows 25,000 patients undergoing HCV treatment—one of the most comprehensive initiatives in Italy in the fight against hepatitis.

🌍 Global Collaborations and Humanitarian Engagement

Her impact extends beyond Italy, thanks to her active involvement with the U.S.-based American Clinical Trials Group on HIV studies. These collaborations have enhanced international understanding and treatment of HIV/AIDS. In addition to her clinical and research commitments, Dr. Weimer also devoted herself to frontline service during the COVID-19 pandemic. Volunteering both with the Civil Protection unit and at Bambino Gesù Children’s Hospital, she demonstrated profound humanitarian values. Her presence during a critical time underscored her belief in serving communities not just from behind a lab desk but also on the ground, directly supporting patients and health systems under strain.

🏅 Accolades and Recognition

Dr. Weimer’s work has been acknowledged at both national and international levels. One of the most prominent recognitions she received was the 1st Prize at the International Congress on Hepatitis C held in Seville in November 2019, a testament to her excellence and influence in the field of infectious disease research. Her achievements are not only measured in accolades but also in the tangible difference her work has made in advancing therapy options and clinical management of chronic viral diseases. Her rise within the ISS and the trust placed in her leadership of major research projects further affirm her standing within the scientific community.

💡 Impact and Influence

Over the course of her extensive career, Dr. Weimer has significantly shaped clinical research strategies in Italy, especially regarding chronic viral infections. Her coordination of thousands of patient cases within structured clinical trials has informed policy decisions and improved treatment protocols nationwide. Her presence at the ISS has also influenced future generations of researchers and clinicians, many of whom benefited from her mentorship, leadership, and example of scientific integrity. Through her rigorous methods and patient-focused approach, she has played a key role in Italy’s standing as a leader in global health research, especially in relation to HIV and HCV.

🔬 Legacy and Future Contributions

Looking forward, Dr. Weimer’s contributions will continue to echo through the fields of virology and clinical medicine. Her involvement in the PITER cohort and other studies has laid down essential groundwork for long-term epidemiological surveillance and patient care strategies. With her appointment as First Researcher, she enters a new chapter of leadership, likely to drive more innovative, patient-centered research initiatives in global health. Her legacy lies not only in her publications or awards but also in the thousands of lives improved by the treatments she helped to test, refine, and implement. The combination of scientific rigor and heartfelt service defines her enduring contribution to modern medicine.

Publication

  • Outcome of sustained virological responders with histologically advanced chronic hepatitis C – TR Morgan, MG Ghany, HY Kim, KK Snow, ML Shiffman, JL De Santo, … – 2010

 

  • Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5‐year follow‐up of 150 patients – SL George, BR Bacon, EM Brunt, KL Mihindukulasuriya, J Hoffmann, … – 2009

 

  • Safety and efficacy of simeprevir/sofosbuvir in hepatitis C–infected patients with compensated and decompensated cirrhosis – V Saxena, L Nyberg, M Pauly, A Dasgupta, A Nyberg, B Piasecki, … – 2015

 

  • Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy – D Persaud, SC Ray, J Kajdas, A Ahonkhai, GK Siberry, K Ferguson, … – 2007

 

  • Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real‐world cohort study – EB Tapper, BR Bacon, MP Curry, DT Dieterich, SL Flamm, LE Guest, … – 2016

 

  • Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with< 50 copies/ml HIV-1 RNA – S Baroncelli, CM Galluzzo, MF Pirillo, MG Mancini, LE Weimer, … – 2009

 

  • Predictors of failure with high-flow nasal oxygen therapy in COVID-19 patients with acute respiratory failure: a multicenter observational study – R Mellado-Artigas, LE Mujica, ML Ruiz, BL Ferreyro, F Angriman, E Arruti, … – 2021

 

  • A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients – M Floridia, R Bucciardini, D Ricciardulli, V Fragola, MF Pirillo, LE Weimer, … – 1999

 

  • Modeling cost‐effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real‐life cohort – LA Kondili, F Romano, FR Rolli, M Ruggeri, S Rosato, MR Brunetto, … – 2017

 

  • Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER network – LA Kondili, GB Gaeta, D Ieluzzi, AL Zignego, M Monti, A Gori, A Soria, … – 2017

 

🏁 Conclusion

Dr. Weimer stands as a distinguished figure in the field of global health research, with deep expertise in clinical trials and infectious diseases. Her legacy is marked by landmark contributions to HIV and HCV treatment protocols, influential collaborations, and compassionate public service. Her ongoing work continues to shape public health policy and medical research in Italy and beyond. As she advances in her leadership role at the ISS, her experience, insight, and dedication will remain vital to future innovations in clinical research and global health.

Baoman Li | Neuroanatomy | Best Researcher Award

Published on by Neuroscientists

Prof. Baoman Li | Neuroanatomy | Best Researcher Award

Prof. Baoman Li, China Medical University,  China.

Professor Baoman Li stands at the forefront of contemporary neuroscience and pharmacology, merging deep academic knowledge with impactful translational research. From his foundational training at China Medical University to his postdoctoral work in the United States, he has consistently demonstrated excellence in exploring the physiological and molecular mechanisms of the central nervous system. Currently a Professor and Department Director, his work has revealed novel insights into cerebrospinal fluid transport, neuronal excitability regulation, and bipolar disorder modeling. These discoveries have been featured in top-tier journals such as PNAS, Cell Metabolism, and Molecular Psychiatry.

Profile

Scopus

🎓 Early Academic Pursuits

Baoman Li’s journey into the world of biomedical science began with a strong academic foundation. He pursued his Ph.D. in Medical Pharmacology at China Medical University, where he cultivated a keen interest in the intersection of neuroscience, pharmacology, and toxicology. His early research provided him with an in-depth understanding of neural mechanisms and laid the groundwork for his future innovations. Eager to expand his international experience, he furthered his postdoctoral research at the University of Rochester Medical Center (USA) from 2013 to 2014, where he deepened his expertise in neuropharmacological research.

🧪 Professional Endeavors

Currently serving as a Professor and Department Director at the Forensic Analytical Toxicology Department of China Medical University, Professor Li leads a dynamic team of researchers and scholars. His leadership has not only enhanced academic standards within the department but has also positioned it as a center of excellence in the field of neuroglial research and forensic toxicology. His multidisciplinary approach merges analytical science with neuroscience, significantly advancing our understanding of central nervous system (CNS) function and dysfunction.

🧠 Contributions and Research Focus

Professor Li’s research focuses on cutting-edge discoveries related to neural mechanisms, cerebrospinal fluid dynamics, and neuropsychiatric disorders. One of his landmark studies, published in PNAS (2024), identified ependymal cell-mediated cerebrospinal fluid transport from the CNS to peripheral organs, revealing a critical physiological communication pathway. In another pivotal contribution in Cell Metabolism (2025), he elucidated the role of the NE-FFA-Na⁺/K⁺-ATPase pathway in regulating neuronal hyperexcitability and behavioral arousal. Moreover, his groundbreaking development of a circadian disruption-induced manic mouse model for bipolar disorder research (published in Molecular Psychiatry, 2023) has provided a valuable tool for studying mood disorders and developing new therapeutic approaches.

📚 Academic Publications and Editorial Work

With an impressive academic portfolio, Professor Li has authored and edited three influential books centered on neuroglial science, expanding the literature in this specialized domain. His published works include notable titles with ISBNs: 978-7-117-34321-3, 978-3-030-77375-5, and 978-2-88963-497-2. These contributions serve as essential resources for both emerging and seasoned neuroscientists, offering detailed insights into glial biology, neurochemical interactions, and translational research.

🏅 Accolades and Recognition

Professor Li’s scholarly excellence is widely recognized, as reflected in his H-index of 34 and a total citation count of 3,530 according to Web of Science. His ability to consistently produce high-impact research has made him a respected voice in neuroscience and pharmacology. He has successfully led eight research projects funded by prestigious bodies such as the Natural Science Foundation of China and the Ministry of Education, while also currently heading two additional projects supported by the provincial science foundation.

🤝 Industry and Consultancy Impact

Beyond academic circles, Professor Li has extended his expertise into practical applications through four consultancy projects, bridging the gap between research and real-world forensic or pharmaceutical needs. His ability to translate complex neuropharmacological findings into actionable insights for the industry underscores his role as not only a theorist but also a problem-solver and innovator.

🔬 Legacy and Future Contributions

As a scientist, educator, and leader, Professor Baoman Li continues to shape the future of neuroscience and pharmacological toxicology. His ongoing research and collaborative efforts are expected to yield further breakthroughs in understanding brain-behavior relationships and disease mechanisms. With a legacy already marked by innovation and impact, his future contributions promise to enhance diagnostics, treatments, and preventive strategies for neurological and psychiatric disorders. His commitment to mentoring young scholars and editing academic literature ensures that his influence will resonate across generations of researchers to come.

Publication

  • Title: Cerebrospinal Fluid Enters Peripheral Organs by Spinal Nerves Supporting Brain–Body Volume Transmission
    Authors: Li, Baoman; Xia, Maosheng; Harkany, Tibor; Verkhratsky, Alexei N.
    Year: Not specified (likely 2024 or 2025)

 

  • Title: Anti-seizure effects of norepinephrine-induced free fatty acid release
    Authors: Li, Baoman; Sun, Qian; Ding, Fengfei; Smith, Nathan A.; Nedergaard, Maiken
    Year: 2025
    Journal: Cell Metabolism

 

  • Title: Major depressive disorder: hypothesis, mechanism, prevention and treatment
    Authors: Cui, Lulu; Li, Shu; Wang, Siman; Xia, Maosheng; Li, Baoman
    Year: Not specified (likely 2024 or 2025)
    Type: Review (Open access)

 

  • Title: The periaxonal space as a conduit for cerebrospinal fluid flow to peripheral organs
    Authors: Li, Xinyu; Wang, Siman; Zhang, Dianjun; Xia, Maosheng; Li, Baoman
    Year: 2024
    Journal: Proceedings of the National Academy of Sciences of the USA (Open access)

 

  • Title: Dexmedetomidine improves the circulatory dysfunction of the glymphatic system induced by sevoflurane through the PI3K/AKT/ΔFosB/AQP4 pathway in young mice
    Authors: Wang, Shuying; Yu, Xiaojin; Cheng, Lili; Lu, Yan; Wu, Xu
    Year: 2024
    Journal: Cell Death and Disease (Open access)

 

  • Title: Ketamine administration causes cognitive impairment by destroying the circulation function of the glymphatic system
    Authors: Wu, Xue; Wen, Gehua; Yan, Lei; Lu, Yan; Wu, Xu
    Year: 2024
    Journal: Biomedicine and Pharmacotherapy (Open access)

 

  • Title: Correction to: Ketamine Improves the Glymphatic Pathway by Reducing the Pyroptosis of Hippocampal Astrocytes in the Chronic Unpredictable Mild Stress Model
    Authors: Wen, Gehua; Zhan, Xiaoni; Xu, Xiaoming; Lu, Yan; Wu, Xu
    Year: 2024
    Journal: Molecular Neurobiology (Erratum, Open access)

 

  • Title: Ketamine Improves the Glymphatic Pathway by Reducing the Pyroptosis of Hippocampal Astrocytes in the Chronic Unpredictable Mild Stress Model
    Authors: Wen, Gehua; Zhan, Xiaoni; Xu, Xiaoming; Lu, Yan; Wu, Xu
    Year: 2024
    Journal: Molecular Neurobiology

 

  • Title: Trace metals and astrocytes physiology and pathophysiology
    Authors: Li, Baoman; Yu, Weiyang; Verkhratsky, Alexei N.
    Year: 2024
    Journal: Cell Calcium

 

Conclusion:

Dr. Baoman Li is a strong and deserving candidate for the Best Researcher Award. His innovative research, publication in high-impact journals, and interdisciplinary contributions demonstrate excellence and sustained scientific productivity. While he can enhance his visibility and further define his leadership role, his current achievements are more than sufficient to merit this prestigious recognition.

 

Alex Armstrong | Systems Neuroscience | Young Scientist Award

Published on by Neuroscientists

Mr. Alex Armstrong | Systems Neuroscience | Young Scientist Award

Mr. Alex Armstrong, University of Illinois, Urbana-Champaign, United States.

Alex Armstrong is an emerging leader in the field of systems neuroscience with a rich academic background and a global research footprint. Starting with a strong foundation in pharmacology from the University of Manchester and early research experience in China, he has built an interdisciplinary career that bridges experimental, computational, and translational neuroscience. His Ph.D. work at the University of Illinois Urbana-Champaign, under the guidance of Prof. Yurii Vlasov, focuses on the neural mechanisms of perceptual decision-making using innovative tools like tactile virtual reality and localized lesioning techniques. He has also played integral roles in teaching, mentoring, and collaborative NIH-funded research involving cutting-edge neural probes. His contributions span from fundamental neuroscience to neuroengineering, with multiple international presentations and a growing reputation in both academic and applied research communities.

Profile

Google Scholar

🎓 Early Academic Pursuits

Alex Armstrong’s journey into the world of neuroscience began with a strong academic foundation in Pharmacology at the University of Manchester, where he earned a BSc (Honors) degree in 2017. During his undergraduate studies, he delved into the neural effects of psychoactive substances, leading a research project examining the influence of various drugs on receptive fields in the rat lateral geniculate nucleus. His academic curiosity was not confined to the lab; Alex actively mentored disadvantaged youth in science and mathematics through the CityWise charity, demonstrating an early commitment to both education and societal impact. His academic appetite took a global turn when he received a competitive scholarship to Nanjing Medical University in China. There, he shadowed urologists and contributed to prostate cancer research by processing tumor samples and supporting manuscript preparation under the mentorship of Dr. Jian Lin. This early immersion into translational research laid the groundwork for his future endeavors in systems neuroscience.

🧠 Research Focus and Innovation

Currently pursuing his Ph.D. at the University of Illinois Urbana-Champaign, Alex Armstrong is at the forefront of neuroscience research under the mentorship of Professor Yurii Vlasov, a member of the National Academy of Engineering. His research seeks to unravel the neural underpinnings of perceptual decision-making using advanced technologies. Alex has pioneered the development of a novel tactile virtual reality system tailored for mice, enabling precise behavioral and neural investigations in ecologically valid scenarios. His contributions also include designing a localized lesioning technique to dissect the causal roles of specific cortical regions with unmatched spatial and temporal resolution. This work reflects his deep integration of behavior, electrophysiology, histology, and computational modeling — a rare confluence of skills that pushes the boundaries of systems neuroscience.

🔬 Professional Endeavors and Laboratory Leadership

Alex’s career includes impactful positions across globally renowned institutions. Prior to his doctoral studies, he served as a Research Technician at University College London, working in auditory neuroscience labs with PIs Jennifer Linden and Nicholas Lesica. There, he independently managed experiments related to auditory perception and hearing aid technology, leading both behavioral training and neural recordings. At UIUC, his laboratory involvement extends beyond individual research: he performs surgeries, manages mouse colonies, trains new graduate and undergraduate researchers, and leads collaborative NIH-funded projects investigating simultaneous electrical and chemical neural activity during seizures. Alex is a dependable pillar in the lab, bridging experiment and innovation through hands-on mentorship and project leadership.

🏆 Accolades and Recognition

Alex’s academic and scientific contributions have been recognized at multiple levels. He has presented his work through nine conference talks and poster presentations at premier forums including Barrels, the Society for Neuroscience, and AREADNE between 2021 and 2024. His visibility within the academic community extends to teaching, where he was entrusted as a Teaching Assistant for the competitive Neural Interface Engineering course (ECE421) in 2024 and 2025, guiding over 50 students through workshops, lessons, and exam reviews. His role on the UIUC neuroscience seminar committee in 2022 further demonstrated his leadership in promoting interdisciplinary dialogue, as he invited top neuroscientists from across the world to contribute to the university’s vibrant intellectual atmosphere.

🧪 Scientific Contributions and Methodological Advancements

One of Alex Armstrong’s most significant contributions lies in his ability to blend experimental neuroscience with computational modeling. His proficiency spans advanced analytical methods including Generalized Linear Models (GLM), Drift Diffusion Models (DDM), Dimensionality Reduction, and DyNetCP, positioning him at the intersection of theory and practice. His work not only provides high-resolution insights into brain function but also informs the design of next-generation neural interface devices. His leadership in testing novel neural probes capable of simultaneously recording both electrical and chemical signals underlines his commitment to tool development in neuroscience — a field critical to brain–machine interface technologies and precision neuromodulation.

🌍 Impact and Influence

Alex Armstrong’s research has both immediate and long-term scientific value. By enhancing our understanding of the cortical mechanisms underlying decision-making, his work informs the broader fields of psychology, cognitive science, and artificial intelligence. His contributions to probe testing during seizure dynamics have implications for epilepsy research, potentially opening doors for better diagnostics and treatment strategies. Furthermore, his global academic experience — spanning the U.K., U.S., and China — contributes to his inclusive scientific perspective and ability to work across cultural and institutional boundaries. He has not only advanced science but also nurtured future researchers through consistent mentoring and training roles.

🚀 Legacy and Future Contributions

Looking ahead, Alex Armstrong is poised to become a leading figure in systems neuroscience, particularly in decoding the neural basis of cognition and behavior. With a solid foundation in experimentation, programming, and tool development, he is uniquely equipped to tackle the grand challenges of brain science in the 21st century. His efforts are steadily laying a legacy of open, interdisciplinary research, bridging the biological and engineering aspects of neuroscience. Whether through innovative VR paradigms for animal behavior, high-density probe validation, or collaborative research across continents, Alex continues to pave the way for future breakthroughs in understanding the human brain.

Publication

  • Title: Targeting AXL overcomes resistance to docetaxel therapy in advanced prostate cancer
    Authors: JZ Lin, ZJ Wang, W De, M Zheng, WZ Xu, HF Wu, A Armstrong, JG Zhu
    Year: 2017

 

  • Title: Compression and amplification algorithms in hearing aids impair the selectivity of neural responses to speech
    Authors: AG Armstrong, CC Lam, S Sabesan, NA Lesica
    Year: 2022

 

  • Title: The hearing aid dilemma: amplification, compression, and distortion of the neural code
    Authors: A Armstrong, CC Lam, S Sabesan, NA Lesica
    Year: 2020

 

  • Title: Nonlinear sensitivity to acoustic context is a stable feature of neuronal responses to complex sounds in auditory cortex of awake mice
    Authors: M Akritas, AG Armstrong, JM Lebert, AF Meyer, M Sahani, JF Linden
    Year: 2024

 

  • Title: Contextual modulation is a stable feature of the neural code in auditory cortex of awake mice
    Authors: M Akritas, AG Armstrong, JM Lebert, AF Meyer, M Sahani, JF Linden
    Year: 2023

 

  • Title: Neuropeptides in the Extracellular Space of the Mouse Cortex Measured by Nanodialysis Probe Coupled with LC-MS
    Authors: K Li, W Shi, Y Tan, Y Ding, A Armstrong, Y Vlasov, J Sweedler
    Year: 2025

 

  • Title: Neural correlates of perceptual decision making in primary somatosensory cortex
    Authors: A Armstrong, Y Vlasov
    Year: 2025

 

  • Title: Perceptual decision-making during whisker-guided navigation causally depends on a single cortical barrel column
    Authors: AG Armstrong, Y Vlasov
    Year: 2025

 

 

✅ Conclusion

Alex Armstrong exemplifies the next generation of neuroscientists—technically skilled, globally experienced, and intellectually versatile. His ability to merge behavioral neuroscience with advanced computational tools and engineering innovations positions him at the forefront of brain research. As he continues to contribute to our understanding of neural dynamics and brain–machine interfaces, Alex is set to leave a lasting impact on neuroscience and its applications in medicine and technology. His trajectory reflects not just scientific excellence, but also a commitment to mentorship, interdisciplinary collaboration, and innovation-driven discovery.